Synthetic hydrogel substrate for human induced pluripotent stem cell definitive endoderm differentiation
pubmed.ncbi.nlm.nih.gov shows its articles on its own site.
Read the article on pubmed.ncbi.nlm.nih.gov ↗Article · Oct 2024 · 1 min read
In brief
In brief
This study develops a fully defined PEG-based hydrogel substrate as a synthetic alternative to Matrigel for differentiating human induced pluripotent stem cells into definitive endoderm. The engineered matrix uses cyclic RGD peptides and optimized stiffness to support efficient differentiation, addressing clinical translatability limitations of current xenogeneic substrates.
Written by the GCMD Library team from the article.
Statements in this article
Human induced pluripotent stem cells can give rise to multiple lineages derived from three germ layers: endoderm, mesoderm and ectoderm.
Matrigel is the gold standard for definitive endoderm differentiation but is a xenogeneic, poorly defined basement membrane extract that limits clinical translatability of definitive endoderm-derived tissues.
A fully defined PEG-based hydrogel substrate presenting cyclic RGD peptide supports the transition from undifferentiated human induced pluripotent stem cells to definitive endoderm using a serum-free, commercially available kit.
Increasing substrate stiffness from G' = 1.0 to 4.0 kPa results in an increased linear response in definitive endoderm differentiation efficiency.
Focal adhesion kinase activity regulates human induced pluripotent stem cell growth and definitive endoderm differentiation efficiency.
